Federal contractor · public award history
EXELAN PHARMACEUTICALS INC
Parent: EXELAN PHARMACEUTICALS INC FYZXNHSQTMG8
- Awards we know about
- 34
- Typical size
- $27,001
- Middle of their public awards
- Dollars on those awards
- $74.79M
Most of their awards we can see fall roughly between $10,035 and $62,415.
From official USAspending contract records — not a capability rating, past-performance score, or recommendation to team or bid.
Public award activity by year
Sum of award values in our USAspending index (not a full financial history).
- 2024$121,673
- 2025$74.67M
Awarding agencies
- Department of Veterans Affairs (33)
- Department of Health and Human Services (1)
Industries & product codes
Award history
- Department of Veterans Affairs—
65 I B, DRUGS, PHARMACEUTICALS,&HEMATOLOGY RELATED PRODUCTS, FSS CONTRACT AWARD
- Department of Veterans Affairs$9,797
EMERGENCY PHARMACY - LENALIDOMIDE, 10 MG, NDC 76282-0698-48
- Department of Veterans Affairs$36,120
LENALIDOMIDE, 10MG, 15MG, 25MG NDCS 6282-0699-47, 76282-0701-47, & 76282-0698-48
- Department of Veterans Affairs$10,035
EMERGENCY PHARMACY LENALIDOMIDE NATIONAL DRUG CODE (NDC) 76282-0699-47
- Department of Veterans Affairs$19,746
LENALIDOMIDE
- Department of Veterans Affairs—
NEW AWARD FOR SILDENAFIL CITRATE TABLETS WITH EXELAN. ORDERING PERIOD IS OCT 27, 2022 TO OCT 26, 2023 WITH FOUR ONE-YEAR OPTIONS
- Department of Veterans Affairs$36,465
LENALIDOMIDE 15MG, 25MG NDCS:76282-0699-47, 76282-0701-47
- Department of Veterans Affairs—
LENALIDOMIDE
- Department of Veterans Affairs$42,663
EMERGENCY PHARMACY BUY
- Department of Veterans Affairs$10,035
LENALIDOMIDE
- Department of Veterans Affairs$13,062
LENALIDOMIDE MEDS
- Department of Veterans Affairs$10,035
LENALIDOMIDE 15MG NDC: 76282-0699-47
- Department of Veterans Affairs$30,104
LENALIDOMIDE
- Department of Veterans Affairs$23,898
EMERGENCY PHARMACY ORDER - LENALIDOMIDE 15MG AND 2.5MG
- Department of Veterans Affairs$10,035
LENALIDOMIDE 15MG
- Department of Health and Human Services$74.06M
OSELTAMIVIR PHOSPHATE 75MG CAPSULES (NDC: 76282-0704-45); 10 CT. BLISTERS PACKS AND OSELTAMIVIR PHOSPHATE 30MG CAPSULES (NDC: 76282-0702-45); 10 CT. BLISTERS PACKS.
- Department of Veterans Affairs—
NEW AWARD FOR IBUPROFEN WITH EXELAN PHARMACEUTICALS EFFECTIVE 06/20/2022 - 06/19/2023
- Department of Veterans Affairs—
NEW AWARD FOR TAMSULOSIN HCL 0.4MG CAPSULES WITH EXELAN PHARMACEUTICALS INC. ORDERING PERIOD IS SEPT. 7, 2025 TO SEPT. 6, 2026 WITH FOUR ONE-YEAR OPTIONS
- Department of Veterans Affairs—
NEW AWARD FOR DICLOFENAC SODIUM 1% TOPICAL GEL WITH EXELAN PHARMACEUTICALS, INC. ORDERING PERIOD IS SEPTEMBER 3, 2025 TO SEPTEMBER 2, 2026 WITH FOUR ONE-YEAR OPTIONS.
- Department of Veterans Affairs—
NEW AWARD FOR ZONISAMIDE CAPSULES WITH EXELAN PHARMACEUTICALS, INC. PERIOD OF PERFORMANCE IS JUNE 15, 2021 TO JUNE 14, 2022 WITH FOUR 0NE-YEAR OPTIONS.
- Department of Veterans Affairs—
6 LINE ITEMS FOR PRAZOSIN HCL CAPSULES. AWARDED FOR A BASE YEAR OF 2/19/2023 TO 2/18/2024 WITH FOUR ONE-YEAR OPTION PERIODS.
- Department of Veterans Affairs—
6 LINE ITEMS FOR CYCLOBENZAPRINE TABLETS. AWARDED FOR A BASE YEAR OF 6/3/2025 TO 6/2/2026 WITH 4 ONE-YEAR OPTION PERIODS.
- Department of Veterans Affairs—
(VA), ALL ORDERING ACTIVITIES UNDER THE DEPARTMENT OF DEFENSE (DOD) PHARMACEUTICAL PRIME VENDOR PROGRAM, (IHS), (BOP), OPTION 2 STATE VETERANS HOMES, AND (FHCC)
- Department of Veterans Affairs—
NEW AWARD FOR NADOLOL TABLETS WITH EXELAN PHARMACEUTICALS, INC.. PERIOD OF PERFORMANCE IS JULY 1, 2020 TO JUNE 30, 2021 WITH FOUR ONE-YEAR OPTIONS.
- Department of Veterans Affairs—
NEW AWARD FOR OSELTAMIVIR PHOSPHATE CAPSULES AND SUSPENSION WITH EXELAN. PERIOD OF PERFORMANCE 2-22-2024 - 2-21-2025.
- Department of Veterans Affairs—
1 LINE ITEM FOR DICLOFENAC NA 1% GEL. AWARDED FOR A BASE YEAR AND 4 1-YEAR OPTION PERIODS. BASE YEAR PERIOD OF PERFORMANCE IS 6/15/2020-6/14/2021.
- Department of Veterans Affairs—
NEW AWARD FOR ESCITALOPRAM OXALATE TABLETS WITH EXELAN. PERIOD OF PERFORMANCE IS MAR 17, 2024 TO MAR 16, 2025 WITH FOUR ONE-YEAR OPTIONS.
- Department of Veterans Affairs—
NEW AWARD FOR LISINOPRIL TABLETS WITH EXELAN. PERIOD OF PERFORMANCE IS FEB 12, 2022 TO FEB 11, 2023 WITH FOUR ONE-YEAR OPTIONS.
- Department of Veterans Affairs—
NEW AWARD FOR PREGABALIN CAPSULES WITH EXELAN PHARMACEUTICALS. PERIOD OF PERFORMANCE IS MARCH 2, 2021 TO MARCH 01, 2022 WITH FOUR ONE-YEAR OPTIONS
- Department of Veterans Affairs—
NEW AWARD FOR RAMIPRIL CAPSULES WITH EXELAN PHARMACEUTICALS INC. THE PERIOD OF PERFORMANCE IS MARCH 14, 2022 TO MARCH 13, 2023 WITH FOUR ONE-YEAR OPTIONS.
- Department of Veterans Affairs—
NEW AWARD FOR TOPIRAMATE TABLETS WITH EXELAN PHARMACEUTICALS, INC. PERIOD OF PERFORMANCE IS 10/31/2020 TO 10/30/2021 WITH FOUR ONE-YEAR OPTIONS.
- Department of Veterans Affairs$131,195
DELIVERY ORDER FOR IBUPROFEN TABLETS CONTRACT WITH EXELAN PHARMACEUTICALS FOR REPACKAGING PROGRAM.
- Department of Veterans Affairs$228,558
DELIVERY ORDER FOR IBUPROFEN WITH EXELAN PHARMACEUTICALS FOR THE REPACKAGING PROGRAM.
- Department of Veterans Affairs$121,673
DELIVERY ORDER FOR IBUPROFEN TABLETS UNDER CONTRACT WITH EXELAN PHARMACEUTICALS FOR THE REPACKAGING PROGRAM.
Intelligence only — not legal advice, not a past-performance evaluation, and not a recommendation to team or bid. Verify on USAspending and SAM.gov.